A systematic review of the outcomes reported in trials of medication review in older patients: the need for a core outcome set

Jean-Baptiste Beuscart, Lisa G. Pont, Stefanie Thevelin, Benoit Boland, Olivia Dalleur, Anne W.S. Rutjes, Johanna I. Westbrook, Anne Spinewine

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Aim: Medication review has been advocated as one of the measures to tackle the challenge of polypharmacy in older patients, yet there is no consensus on how best to evaluate its efficacy. This study aimed to assess outcome reporting in trials of medication review in older patients. Methods: Randomized controlled trials (RCTs), prospective studies and RCT protocols involving medication review performed in patients aged 65 years or older in any setting of care were identified from: (1) a recent systematic review; (2) RCT registries of ongoing studies; (3) the Cochrane library. The type, definition, and frequency of all outcomes reported were extracted independently by two researchers. Results: Forty-seven RCTs or prospective published studies and 32 RCT protocols were identified. A total of 327 distinct outcomes were identified in the 47 published studies. Only one fifth (21%) of the studies evaluated the impact of medication reviews on adverse events such as drug reactions or drug-related hospital admissions. Most of the outcomes were related to medication use (n = 114, 35%) and healthcare use (n = 74, 23%). Very few outcomes were patient-related (n = 24, 7%). A total of 248 distinct outcomes were identified in the 32 RCT protocols. Overall, the number of outcomes and the number and type of health domains covered by the outcomes varied largely. Conclusion: Outcome reporting from RCTs concerning medication review in older patients is heterogeneous. This review highlights the need for a standardized core outcome set for medication review in older patients, to improve outcome reporting and evidence synthesis.

LanguageEnglish
Pages942-952
Number of pages11
JournalBritish Journal of Clinical Pharmacology
Volume83
Issue number5
DOIs
Publication statusPublished - 1 May 2017

Fingerprint

Randomized Controlled Trials
Clinical Protocols
Prospective Studies
Polypharmacy
Pharmaceutical Preparations
Libraries
Registries
Research Personnel
Delivery of Health Care
Health

Keywords

  • elderly
  • medication review
  • outcomes assessment
  • randomized controlled trials
  • systematic review

Cite this

Beuscart, Jean-Baptiste ; Pont, Lisa G. ; Thevelin, Stefanie ; Boland, Benoit ; Dalleur, Olivia ; Rutjes, Anne W.S. ; Westbrook, Johanna I. ; Spinewine, Anne. / A systematic review of the outcomes reported in trials of medication review in older patients : the need for a core outcome set. In: British Journal of Clinical Pharmacology. 2017 ; Vol. 83, No. 5. pp. 942-952.
@article{e2807c68471f497d8cb92c1adddb517b,
title = "A systematic review of the outcomes reported in trials of medication review in older patients: the need for a core outcome set",
abstract = "Aim: Medication review has been advocated as one of the measures to tackle the challenge of polypharmacy in older patients, yet there is no consensus on how best to evaluate its efficacy. This study aimed to assess outcome reporting in trials of medication review in older patients. Methods: Randomized controlled trials (RCTs), prospective studies and RCT protocols involving medication review performed in patients aged 65 years or older in any setting of care were identified from: (1) a recent systematic review; (2) RCT registries of ongoing studies; (3) the Cochrane library. The type, definition, and frequency of all outcomes reported were extracted independently by two researchers. Results: Forty-seven RCTs or prospective published studies and 32 RCT protocols were identified. A total of 327 distinct outcomes were identified in the 47 published studies. Only one fifth (21{\%}) of the studies evaluated the impact of medication reviews on adverse events such as drug reactions or drug-related hospital admissions. Most of the outcomes were related to medication use (n = 114, 35{\%}) and healthcare use (n = 74, 23{\%}). Very few outcomes were patient-related (n = 24, 7{\%}). A total of 248 distinct outcomes were identified in the 32 RCT protocols. Overall, the number of outcomes and the number and type of health domains covered by the outcomes varied largely. Conclusion: Outcome reporting from RCTs concerning medication review in older patients is heterogeneous. This review highlights the need for a standardized core outcome set for medication review in older patients, to improve outcome reporting and evidence synthesis.",
keywords = "elderly, medication review, outcomes assessment, randomized controlled trials, systematic review",
author = "Jean-Baptiste Beuscart and Pont, {Lisa G.} and Stefanie Thevelin and Benoit Boland and Olivia Dalleur and Rutjes, {Anne W.S.} and Westbrook, {Johanna I.} and Anne Spinewine",
year = "2017",
month = "5",
day = "1",
doi = "10.1111/bcp.13197",
language = "English",
volume = "83",
pages = "942--952",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "BLACKWELL SCIENCE LTD",
number = "5",

}

A systematic review of the outcomes reported in trials of medication review in older patients : the need for a core outcome set. / Beuscart, Jean-Baptiste; Pont, Lisa G.; Thevelin, Stefanie; Boland, Benoit; Dalleur, Olivia; Rutjes, Anne W.S.; Westbrook, Johanna I.; Spinewine, Anne.

In: British Journal of Clinical Pharmacology, Vol. 83, No. 5, 01.05.2017, p. 942-952.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - A systematic review of the outcomes reported in trials of medication review in older patients

T2 - British Journal of Clinical Pharmacology

AU - Beuscart, Jean-Baptiste

AU - Pont, Lisa G.

AU - Thevelin, Stefanie

AU - Boland, Benoit

AU - Dalleur, Olivia

AU - Rutjes, Anne W.S.

AU - Westbrook, Johanna I.

AU - Spinewine, Anne

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Aim: Medication review has been advocated as one of the measures to tackle the challenge of polypharmacy in older patients, yet there is no consensus on how best to evaluate its efficacy. This study aimed to assess outcome reporting in trials of medication review in older patients. Methods: Randomized controlled trials (RCTs), prospective studies and RCT protocols involving medication review performed in patients aged 65 years or older in any setting of care were identified from: (1) a recent systematic review; (2) RCT registries of ongoing studies; (3) the Cochrane library. The type, definition, and frequency of all outcomes reported were extracted independently by two researchers. Results: Forty-seven RCTs or prospective published studies and 32 RCT protocols were identified. A total of 327 distinct outcomes were identified in the 47 published studies. Only one fifth (21%) of the studies evaluated the impact of medication reviews on adverse events such as drug reactions or drug-related hospital admissions. Most of the outcomes were related to medication use (n = 114, 35%) and healthcare use (n = 74, 23%). Very few outcomes were patient-related (n = 24, 7%). A total of 248 distinct outcomes were identified in the 32 RCT protocols. Overall, the number of outcomes and the number and type of health domains covered by the outcomes varied largely. Conclusion: Outcome reporting from RCTs concerning medication review in older patients is heterogeneous. This review highlights the need for a standardized core outcome set for medication review in older patients, to improve outcome reporting and evidence synthesis.

AB - Aim: Medication review has been advocated as one of the measures to tackle the challenge of polypharmacy in older patients, yet there is no consensus on how best to evaluate its efficacy. This study aimed to assess outcome reporting in trials of medication review in older patients. Methods: Randomized controlled trials (RCTs), prospective studies and RCT protocols involving medication review performed in patients aged 65 years or older in any setting of care were identified from: (1) a recent systematic review; (2) RCT registries of ongoing studies; (3) the Cochrane library. The type, definition, and frequency of all outcomes reported were extracted independently by two researchers. Results: Forty-seven RCTs or prospective published studies and 32 RCT protocols were identified. A total of 327 distinct outcomes were identified in the 47 published studies. Only one fifth (21%) of the studies evaluated the impact of medication reviews on adverse events such as drug reactions or drug-related hospital admissions. Most of the outcomes were related to medication use (n = 114, 35%) and healthcare use (n = 74, 23%). Very few outcomes were patient-related (n = 24, 7%). A total of 248 distinct outcomes were identified in the 32 RCT protocols. Overall, the number of outcomes and the number and type of health domains covered by the outcomes varied largely. Conclusion: Outcome reporting from RCTs concerning medication review in older patients is heterogeneous. This review highlights the need for a standardized core outcome set for medication review in older patients, to improve outcome reporting and evidence synthesis.

KW - elderly

KW - medication review

KW - outcomes assessment

KW - randomized controlled trials

KW - systematic review

UR - http://www.scopus.com/inward/record.url?scp=85010208999&partnerID=8YFLogxK

U2 - 10.1111/bcp.13197

DO - 10.1111/bcp.13197

M3 - Article

VL - 83

SP - 942

EP - 952

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 5

ER -